Thursday, December 8, 2022

Centene sells Magellan Rx to Prime Therapeutics Centene sells Magellan Rx to Prime Therapeutics Centene sells Magellan Rx to Prime Therapeutics

Centene sells Magellan Rx to Prime Therapeutics

This sale advances Centene's value creation initiative, which aims to increase profits through divestitures and leadership changes.



from Section Page News - Modern Healthcare https://ift.tt/jNirIsT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)